Integrin αvβ3 is a Potential Therapeutic Target in Cholangiocarcinoma
International Journal of Medical Sciences · 2026
DOI: 10.7150/ijms.125066 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2026. Verfasst von Fitria Sari Wulandari und 18 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031…. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Integrin alphaVbeta3, Bile Duct Neoplasms, Thyroxine. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.
- Department of Surgery, Division of Neurosurgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
- TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan.
- Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USA.
- Department of Pediatrics, E-DA Hospital, I-Shou University, Kaohsiung 82445, Taiwan.
- School of Medicine, college of Medicine, I-Shou University, Kaohsiung 82445, Taiwan.
Zitieren
APA
Wulandari, F. S., Wang, C. Y., Crawford, D. R., Yang, Y. N., Then, C. K., Kumar, S., Suk, F. M., Huang, L. Y., Yang, Y. S., Li, Z. L., Shih, Y. J., Tu, H. T., Wang, K., Phu, H. D., Lin, C. M., Xuan, D. T. M., Solomon, D. D., Lin, H. Y., & Whang-Peng, J. (2026). Integrin αvβ3 is a Potential Therapeutic Target in Cholangiocarcinoma. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.125066
Vancouver
Wulandari FS, Wang CY, Crawford DR, Yang YN, Then CK, Kumar S, et al. Integrin αvβ3 is a Potential Therapeutic Target in Cholangiocarcinoma. International Journal of Medical Sciences. 2026. doi:10.7150/ijms.125066
BibTeX
@article{Wulandari2026,
author = {Wulandari, Fitria Sari and Wang, Chih-Yang and Crawford, Dana R and Yang, Yung-Ning and Then, Chee-Kin and Kumar, Sachin and Suk, Fat-Moon and Huang, Lin-Yi and Yang, Yu-Chen Sh and Li, Zi-Lin and Shih, Ya-Jung and Tu, Hoai Tran and Wang, Kuan and Phu, Hoang Dang and Lin, Chun-Mao and Xuan, Do Thi Minh and Solomon, Dahlak Daniel and Lin, Hung-Yun and Whang-Peng, Jacqueline},
title = {Integrin αvβ3 is a Potential Therapeutic Target in Cholangiocarcinoma},
journal = {International Journal of Medical Sciences},
year = {2026},
doi = {10.7150/ijms.125066}
}
EUVIMED